Implant Sciences develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. IMSC’s patented technologies provide unique screening capabilities to extend and improve counter-terrorist and homeland security efforts. Read our due diligence report from the last year here.
Yesterday, January 16th, Implant announced that company is hosting a conference call to to update investors on “recent developments”. We emailed our subscribers what to expect from this call:
The most logical conclusion is that the TSA approval that launches IMSC’s trace detection technology in the United States is finally here. This landmark deal has been coming for YEARS.
Our advice? Tune into the call.
Implant Sciences Corporation (IMSC) announced today that the U.S. Transportation Security Administration (TSA) has notified the Company that its Quantum Sniffer™ QS-B220 Explosives Trace Detector has successfully met the requirements for acceptance onto the Air Cargo Screening Technology List (ACSTL).